Cancer Research UK logo.
SearchDonate
  • Search

A trial of chemotherapy and durvalumab for bladder cancer (NIAGRA)

Overview

Cancer types:

Bladder cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at adding durvalumab to chemotherapy for people with bladder cancer that has grown into the muscle wall. This is invasive bladder cancer.

It is for people due to have surgery to remove their bladder. This surgery is called a cystectomy.

Recruitment start: 6 August 2019

Recruitment end: 30 July 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tom Powles

Supported by

AstraZeneca

Last reviewed: 04 Aug 2021

CRUK internal database number: 16661

Help and support